Profound Medical Corp.
PRN.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -41.12M | -32.34M | -28.20M | -31.53M | -27.73M |
| Total Depreciation and Amortization | 739.00K | 832.00K | 919.00K | 789.00K | 853.00K |
| Total Amortization of Deferred Charges | -91.00K | -91.00K | -91.00K | 45.00K | -- |
| Total Other Non-Cash Items | 2.64M | 2.01M | 1.83M | 3.46M | 3.64M |
| Change in Net Operating Assets | 3.80M | 3.09M | 2.79M | 2.79M | 823.00K |
| Cash from Operations | -34.03M | -26.51M | -22.75M | -24.44M | -22.42M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.48M | -2.08M | -2.42M | -2.10M | -1.62M |
| Issuance of Common Stock | 39.21M | 39.21M | 62.15M | 22.94M | 22.95M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.04M | -3.04M | -4.90M | -1.86M | -1.86M |
| Cash from Financing | 34.70M | 34.10M | 54.84M | 18.99M | 19.47M |
| Foreign Exchange rate Adjustments | 450.00K | -2.34M | -3.39M | -1.05M | -2.25M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.12M | 5.25M | 28.70M | -6.50M | -5.20M |